In a filing, Amedisys Inc revealed its Chief Accounting Officer Guidroz Allyson unloaded Company’s shares for reported $35904.0 on May 08 ’25. In the deal valued at $96.00 per share,374 shares were sold. As a result of this transaction, Guidroz Allyson now holds 8,114 shares worth roughly $0.79 million.
Then, Guidroz Allyson bought 374 shares, generating $35,853 in total proceeds.
Before that, Guidroz Allyson sold 2,041 shares. Amedisys Inc shares valued at $187,833 were divested by the Chief Accounting Officer at a price of $92.03 per share. As a result of the transaction, Guidroz Allyson now holds 8,761 shares, worth roughly $0.85 million.
Deutsche Bank downgraded its Amedisys Inc [AMED] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in early July from “an Outperform” to “a Mkt perform”. Truist also remained covering AMED and has decreased its forecast on June 07, 2023 with a “Hold” recommendation from previously “Buy” rating. Cantor Fitzgerald started covering the stock on April 21, 2023. It rated AMED as “a Neutral”.
Price Performance Review of AMED
On Tuesday, Amedisys Inc [NASDAQ:AMED] saw its stock jump 0.63% to $97.52. Over the last five days, the stock has lost -0.46%. Amedisys Inc shares have fallen nearly -0.24% since the year began. Nevertheless, the stocks have risen 7.41% over the past one year. While a 52-week high of $98.62 was reached on 06/25/25, a 52-week low of $82.15 was recorded on 02/21/25.
Levels Of Support And Resistance For AMED Stock
The 24-hour chart illustrates a support level at 97.04, which if violated will result in even more drops to 96.57. On the upside, there is a resistance level at 97.83. A further resistance level may holdings at 98.14.
How much short interest is there in Amedisys Inc?
A steep rise in short interest was recorded in Amedisys Inc stocks on 2025-07-15, growing by 0.28 million shares to a total of 2.24 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 1.97 million shares. There was a rise of 12.31%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 13, 2023 when Barclays began covering the stock and recommended ‘”an Equal weight”‘ rating along with a $93 price target.
